Joseph Nasr MD

3 Articles

First-in-human Trial of CRISPR Gene-editing ANGPTL3 Safely Lowered Cholesterol and Triglycerides

Key Points: CTX310 is a first-in-class in vivo CRISPR-Cas9 therapy designed to…

Oral KCl Supplementation Lowers Sodium Load and Blood Pressure in Hypertension: SSTT Trial

Key Points The See Sodium to Treat (SSTT) Trial tested whether isolated…

Daily Coffee Lowers AFib Recurrence After Cardioversion: The DECAF Trial

Key Points The Does Eliminating Coffee Avoid Fibrillation (DECAF) trial is the…